There are currently 63 ongoing clinical trials involving Uveal Melanoma
Of the 63 trials,20 trials are in Phase II
Furthermore, 18 trials are in Phase I/II
The global pharmaceutical industry is steadily developing new drugs for Uveal Melanoma, an Oncology condition. The largest number of ongoing clinical trials for Uveal Melanoma is conducted in North America. Europe and Asia-Pacific are among some of the other prominent regions engaged in Uveal Melanoma-related drug trials.
University of Texas MD Anderson Cancer Center: The leading ongoing Uveal Melanoma related clinical trial sponsor
University of Texas MD Anderson Cancer Center is the top sponsor for Uveal Melanoma-related ongoing clinical trials.
Herbert Irving Comprehensive Cancer Center, Thomas Jefferson University Hospitals, Columbia University and University of Virginia are among other notable clinical trial sponsors involved in Uveal Melanoma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward